A preliminary small study on 29 patients with TA observed higher plasma levels of the complement protein iC3b (inactivated C3b) and lower levels of the soluble form of the platelet-endothelium adhesion molecule (PECAM-1, also known as CD31) and of iC5b-9 [86]. This evidence concerns the gene PECAM1 and Takayasu arteritis.